3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Ductal Adenocarcinoma
1
Interventions
Pancreaticoduodenectomy
2
titanium silicide
1
tislelizumab
1
sonidegib
1
paricalcitol
1
mitazalimab
1
lenvatinib
1
ivosidenib
1
irinotecan sucrosofate
1
glucoraphanin
1
devimistat
1
Transurethral Resection of Prostate
1
Tissue Banks
1
Specimen Handling
1
Saline Solution
1
S 1 (combination)
1
Ropivacaine
1
Robotic Surgical Procedures
1
Radiomics
1
Positron Emission Tomography Computed Tomography
1
Parturition
1
PEGPH20
1
Oxaliplatin
1
Neoadjuvant Therapy
1
Magnetic Resonance Spectroscopy
1
Losartan
1
Irinotecan
1
Immunotherapy
1
Hydroxychloroquine
1
Glucose
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pancreatic Ductal Adenocarcinoma
×
glucoraphanin
×
Clear all
NCT01879878
2015-05-28
POUDER
Heidelberg University
Phase NA
Unknown
40 enrolled